IGF1 and Hyperinsulinemia: Although GH levels are reduced in obesity, hyperinsulinemia raises density and sensitivity of hepatic GH-receptors in diabetic and obese patients [97], leading to overproduction of IGF-1 [98] and increasing its availability by decreasing IGFBP-1 levels [99].